research Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
A woman's hair turned white after taking a cancer drug called dasatinib.
Search
for
Did you mean Acute Myelogenous Leukemia?
Learn
0 / 0 results — no results
Research
5 / 132 results research Sterile Suppurative Folliculitis Associated with Acute Myeloblastic Leukemia
A rare skin condition linked to leukemia improved with chemotherapy.
research Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis
Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.
research A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.
research Nilontinib induced keratosis pilaris atrophicans
A 46-year-old man with chronic myelogenous leukemia developed keratosis pilaris-like symptoms, including red bumps and patchy hair loss, after starting nilotinib, a second-generation tyrosine kinase inhibitor. Cutaneous reactions are common non-hematologic side effects of nilotinib, but it was crucial to differentiate these from more severe drug hypersensitivity reactions that might require stopping the medication. Proper classification of skin eruptions based on their morphology, rather than broadly categorizing them as "chemotherapy eruptions," was emphasized for better management of these adverse effects.
Community Join
0 / 0 results — no results